Live from the NIH registry
Studies recruiting near Myrtle Beach right now
Top 25 of 89 recruiting studies, sorted by proximity — each links to its official registry page
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Steba Biotech S.A.
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Pfizer
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Insomnia Disorder
Phase 3
Interventional 420 participants sought
Vanda Investigational Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Vanda Pharmaceuticals
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Non-muscle-invasive Bladder Cancer, NMIBC
Phase 1
Interventional 55 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Aura Biosciences
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Non-muscle Invasive Bladder Cancer
Phase 1
Interventional 294 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Pfizer
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Non-muscle-invasive Bladder Cancer
Phase 1, Phase 2
Interventional 75 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: SURGE Therapeutics
PSMA PET Combined With MRI for the Detection of PCa
PCA, Prostate Cancer
Phase 3
Interventional 338 participants sought
Atlantic Urology Specialists — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
The ArtixASCEND Study
Acute Lower Limb Arterial Occlusion
N/A
Interventional 250 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Inari Medical
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 320 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AstraZeneca
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Phase 3
Interventional 70 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: UroGen Pharma Ltd.
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2
Interventional 325 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: CG Oncology, Inc.
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
Prostate Cancer
Phase 1, Phase 2
Interventional 300 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AstraZeneca
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12111 — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 641 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Janssen Research & Development, LLC
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma
Phase 3
Interventional 284 participants sought
START - Carolinas — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Protara Therapeutics
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Metastatic Castration-Resistant Prostate Cancer
Phase 3
Interventional 900 participants sought
AUC Urologists, LLC — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Pfizer
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 75 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Kyntra Bio
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer
Phase 2
Interventional 131 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Protara Therapeutics
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 1, Phase 2
Interventional 350 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: enGene, Inc.
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Metastatic Castration-resistant Prostate Cancer
Phase 1
Interventional 60 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Daiichi Sankyo
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
TMA Headlands LLC /ID# 259800 — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AbbVie
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 1, Phase 2
Interventional 235 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Janssen Research & Development, LLC
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2
Interventional 400 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Dendreon
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients
Phase 1
Interventional 144 participants sought
Carolina Urologic Research Center, the START Center for Cancer Research — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: K36 Therapeutics, Inc.
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma
Phase 1, Phase 2
Interventional 224 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Pfizer